You are here

Heart Failure

 - Patient

BOSTON—A novel approach known as baroreflex activation therapy led to a 30 percent improvement in New York Heart Association  classification and an increase in quality of life among patients with heart failure and reduced ejection fraction who had failed previous therapies.

 - warning

The FDA issued a Class I recall on a component of the HeartWare Ventricular Assist System. This latest recall targets a splice repair kit that fails when exposed to excessive force.

 - Stress

Mental stress among heart failure patients led to a significant increase in heart rate and diastolic and systolic blood pressure in a study of patients who prepared and gave a speech about their personal strengths and weaknesses.

 - hospital

Approximately 10 percent to 15 percent of patients had worsening heart failure or died within five days of being admitted into a hospital for acute heart failure, according to a pooled analysis of clinical trials.

 - toast

Moderate wine consumption may lighten the outlook for patients with chronic heart failure but it may not make any difference in long-term outcomes, based on results from a large Italian study.

 

More Stories

FDA panel favors heart failure warning on saxagliptin’s labeling

An FDA advisory panel recommended that labeling for the diabetes drug saxagliptin include a warning about a risk of heart failure. The panel determined that the drug’s overall cardiovascular risk was acceptable.

Phenomapping analysis identifies groups of heart failure patients

A phenomapping analysis of patients hospitalized for heart failure found that heart failure with preserved ejection fraction is a heterogeneous disorder and contains mutually exclusive groups with similar characteristics.

Statement on treating patients with hypertension and heart failure

The statement from the American Heart Association (AHA), American College of Cardiology (ACC) and American Society of Hypertension (ASH) updated guidelines from 2007.

Analysis shows 15% of HeartWare recipients develop gastro bleeding

Approximately 15 percent of patients with advanced heart failure experienced gastrointestinal bleeding after receiving the HeartWare Ventricular Assist Device System. However, none of the events impacted survival, and no surgical intervention was needed.

Stroke risk may be high for some patients with heart failure but no a-fib

While guidelines warn against giving anticoagulation to patients with heart failure but without atrial fibrillation, there may be some evidence that a subgroup of these patients may be at increased risk for stroke and could benefit from additional therapy.

Caregivers of destination LVAD patients benefit from support, too

Patients aren’t the only ones impacted by destination therapy left ventricle assist device (LVAD) implants. Caregivers should be part of decision-making and they need support and tools to help them process the change, according to a study.

Sunshine Heart suspends trial after reports of deaths

Sunshine Heart put its U.S. pivotal clinical trial on hold after receiving reports of four deaths among the study’s participants.

HeartWare recall targets clinical trial participants

HeartWare International issued a voluntary recall in the U.S. of older controllers that were distributed during clinical trials.

Donor heart acceptance rate drops as demand rises

Despite growing waiting lists and national efforts to increase the use of available donor organs, the rate of hearts accepted for transplantation has decreased significantly since 1995, a study found.

Cardiologist-driven heart failure care may improve short-term outcomes

Patients with acute decompensated heart failure may benefit more from care by a cardiologist than a non-cardiologist, according to a study published in the February issue of the American Journal of Cardiology.

Review of hospital care finds high rates of IV fluids given for acute heart failure

Early care with intravenous (IV) fluid is not recommended by guidelines for patients with acute decompensated heart failure. However, 11 percent of patients in a study published Feb. 1 in the Journal of the American College of Cardiology: Heart Failure received IV fluid and diuretics in the first two days of hospitalization. 

Pigskins & not porking out

Heart failure is one of the most expensive diseases in the U.S., with many boomerang patients and a stinging financial penalty from Medicare for hospitals with higher than expected 30-day readmissions. It doesn’t need to be that way.

Listen up: Heart failure tool helps ID barriers to self-care

Putting a stop to boomerang heart failure readmissions may require a sympathetic ear in the emergency department (ED). One pilot test has shown that it is possible to identify patients’ barriers to self-care, even in a busy ED setting.

FDA gives pump to support right heart its blessing

The FDA granted Abiomed a Humanitarian Device Exemption for a percutaneous single-access heart pump for patients who develop right heart failure or decompensation.

Super Bowl super bad for intemperate fans with heart failure

Call it Monday morning quarterbacking, but with the chance to actually change the game. Based on one study, hospitals likely will see in uptick in heart failure admissions after Super Bowl Sunday—but cardiologists still have time to coach their patients to play it smart.

LVAD, healer of broken hearts? Heart failure biomarkers suggest yes

A look into cardiomyocytes and DNA damage response may offer new hope for patients with heart failure. Long-term use of left ventricular assist devices (LVADs) may encourage the heart to repair itself at a cellular level.

Something to toast: Moderate drinking may reduce risk for heart failure

A little nip may not hurt the heart. Secondary analysis of Atherosclerosis Risk in Communities data found moderate drinkers had lower risk for cardiovascular events than those who had more to drink or abstained. Findings were similar for both men and women.

Salt shakes its bad rap for upping risk of death, heart diseases

Take it with a grain of salt: In older adults, self-reported sodium intake was not associated with risk for cardiovascular disease, heart failure and mortality, according to a study published online Jan. 19 in JAMA Internal Medicine.

Heart failure discharge summaries miss mark

With Medicare penalties now at 3 percent for 30-day heart failure readmissions, many hospitals are eager to find opportunities to improve outcomes. Based on a study published online Jan. 13, discharge summaries might fit the bill.

Quality of life for heart failure patients may start with accepting illness

The ability to function with heart failure and a patient’s acceptance of his or her condition may go hand in hand. A Polish study used illness acceptance screening to reveal patterns in patient responses to quality of life surveys.